Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday

Author: Avi Kapoor | November 05, 2025 08:48am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Oppenheimer analyst Ken Wong initiated coverage on Docebo Inc. (NASDAQ:DCBO) with an Outperform rating and announced a price target of $35. Docebo shares closed at $24.61 on Tuesday. See how other analysts view this stock.
  • Piper Sandler analyst Biren Amin initiated coverage on Ascentage Pharma Group (NASDAQ:AAPG) with an Overweight rating and announced a price target of $48. Ascentage Pharma shares closed at $33.25 on Tuesday. See how other analysts view this stock.
  • B. Riley Securities analyst Madison El-Saadi initiated coverage on Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) with a Buy rating and announced a price target of $11. Vanda Pharmaceuticals shares closed at $4.35 on Tuesday. See how other analysts view this stock.

Considering buying DCBO stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: AAPG CRVO DCBO QLYS VNDA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist